title: Danaparoid is not a low-molecular-weight heparin.
authors.forename: C D
authors.initials: CD
authors.lastname: Nicholson
authors.forename: D G
authors.initials: DG
authors.lastname: Meuleman
authors.forename: H N
authors.initials: HN
authors.lastname: Magnani
authors.forename: J F
authors.initials: JF
authors.lastname: Egberts
authors.forename: D A
authors.initials: DA
authors.lastname: Leibowitz
authors.forename: S A
authors.initials: SA
authors.lastname: Spinler
authors.forename: M J
authors.initials: MJ
authors.lastname: Cziraky
mesh_terms: D002809:Chondroitin Sulfates / Q000737:chemistry* / Q000627:therapeutic use; D003871:Dermatan Sulfate / Q000737:chemistry* / Q000627:therapeutic use; D004338:Drug Combinations; D006495:Heparin, Low-Molecular-Weight / Q000737:chemistry*; D006496:Heparinoids / Q000737:chemistry; D006497:Heparan Sulfate / Q000737:chemistry* / Q000627:therapeutic use; D006801:Humans; D009626:Terminology as Topic; D013924:Thrombophlebitis / Q000188:drug therapy
chemical_list: D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D004338:Drug Combinations; D006495:Heparin, Low-Molecular-Weight; D006496:Heparinoids; D006497:Heparan Sulfate; C035838:danaparoid